DHS OIG, OIG-15-26, Review of U.S. Customs and Border Protection's FY 2014 Drug Control Performance Summary Report (2015)
DHS OIG
DHS OIG
Review of U.S. Customs and Border Protection's FY 2014 Drug Control Performance Summary Report January 23, 2015 OIG-15-26 HIGHLIGHTS Review of U.S. Customs and Border Protection’s FY 2014 Drug Control Performance Summary Report What We Found KPMG LLP, under contract with the Department of Homeland Security OIG, issued an Independent Accountants’ Report on the U.S. Customs and Border Protection’s (CBP) fiscal year (FY) 2014 Drug Control Performance Summary Report. CBP management prepared the Performance Summary Report and related disclosures to comply with the requirements of ONDCP circular, Accounting of Drug Control Funding and Performance Summary (Circular), dated January 18, 2013. Based on its review, nothing came to KPMG LLP’s attention that caused it to believe that the Performance Summary Report for the year ended September 30, 2014, is not presented, in all material respects, in conformity with the criteria in the ONDCP Circular. KPMG LLP did not make any recommendations as a result of its review.
January 23, 2015 Why We Did This The Office of National Drug Control Policy’s (ONDCP) Circular, Accounting of Drug Control Funding and Performance Summary, requires National Drug Control Program agencies to submit to the ONDCP Director, not later than February 1 of each year, a detailed accounting of all funds expended for National Drug Control Program activities during the previous fiscal year. The Office of Inspector General (OIG) is required to conduct a review of the agency’s submission and provide a conclusion about the reliability of each assertion in the report. For Further Information: Contact our Office of Public Affairs at (202) 254-4100, or email us at [email protected] www.oig.dhs.gov OIG-15-26 y o. ~F ~'`""°{~`'~~ OFFICE OF INSPECTOR GENERAL Department of Homeland Security Washington, DC 20528 / www.oig.dhs.gov 7AN 23 2015 TO: Eugene H. Schied Assistant Commissioner U.S. Customs and Border Protection FROM: Mark Bell ,/~ Assistant Ins- pector General for Audits SUBJECT: Review of U. S. Customs and Border Protection's FY 2014 Drug Control Performance Summary Report, Report Number OIG-15-26 Attached for your information is our final report, Review of U. S. Customs and Border Protection's FY 2014 Drug Control Performance Summary Report. U.S. Customs and Border Protection's (CBP) management prepared the Performance Summary Report and related disclosures to comply with the requirements of the Office of National Drug Control Policy's circular, Accounting of Drug Control Funding and Performance Summary, dated January 18, 2013.
We contracted with the independent public accounting firm, KPMG LLP (KPMG), to review CBP's Drug Control Performance Summary Report. KPMG is responsible for the attached Independent Accountants' Report of its review, dated January 20, 2015, and the conclusions expressed in it. KPMG's report contains no recommendations. Consistent with our responsibility under the Inspector General Act, we will provide copies of our report to appropriate congressional committees with oversight and appropriation responsibility over the Department of Homeland Security.
We will post the report on our website for public dissemination. Please call me with any questions, or your staff may contact Don Bumgardner, Acting Deputy Assistant Inspector General for Audits, at (202) 254-4100. Attachment www. oig. dhs.gov OIG-15-26 KPMG LLP Suite 12000 1801 K Street, NW Washington, DC 20006 Independent Accountants’ Report Inspector General U.S. Department of Homeland Security: We have reviewed the accompanying Performance Summary Report of the U.S. Department of Homeland Security’s (DHS) Customs and Border Protection (CBP) for the year ended September 30, 2014. CBP’s management is responsible for the Performance Summary Report.
Our review was conducted in accordance with attestation standards established by the American Institute of Certified Public Accountants, and applicable standards contained in Government Auditing Standards, issued by the Comptroller General of the United States. A review is substantially less in scope than an examination, the objective of which is the expression of an opinion on the Performance Summary Report. Accordingly, we do not express such an opinion. Management of CBP prepared the Performance Summary Report to comply with the requirements of the Office of National Drug Control Policy (ONDCP) Circular, Accounting of Drug Control Funding and Performance Summary, dated January 18, 2013 (the Circular).
Based on our review, nothing came to our attention that caused us to believe that the Performance Summary Report for the year ended September 30, 2014, referred to above, is not presented, in all material respects, in conformity with the criteria set forth in the Circular. This report is intended solely for the information and use of management of DHS and CBP, the DHS Inspector General, the ONDCP, and the U.S. Congress, and is not intended to be and should not be used by anyone other than these specified parties. January 20, 2015 KPMG LLP is a Delaware limited liability partnership, the U.S. member firm of KPMG International Cooperative (“KPMG International”), a Swiss entity.
Department of Homeland Security Appendix A Report Distribution Department of Homeland Security Secretary Deputy Secretary Chief of Staff General Counsel Executive Secretary Director, GAO/OIG Liaison Office Assistant Secretary for Office of Policy Assistant Secretary for Office of Public Affairs Assistant Secretary for Office of Legislative Affairs U.S. Customs and Border Protection Commissioner Chief Financial Officer Audit Liaison Office of Management and Budget Chief, Homeland Security Branch DHS OIG Budget Examiner Congress Congressional Oversight and Appropriations Committees Office of National Drug Control Policy Associate Director for Management and Administration www.oig.dhs.gov OIG-15-26 ADDITIONAL INFORMATION AND COPIES To view this and any of our other reports, please visit our website at: www.oig.dhs.gov. For further information or questions, please contact Office of Inspector General Public Affairs at: [email protected]. Follow us on Twitter at: @dhsoig.
To report fraud, waste, or abuse, visit our website at www.oig.dhs.gov and click on the red "Hotline" tab. If you cannot access our website, call our hotline at (800) 323-8603, fax our hotline at (202) 254-4297, or write to us at: Department of Homeland Security Office of Inspector General, Mail Stop 0305 Attention: Hotline 245 Murray Drive, SW Washington, DC 20528-0305
Ask CiteLaw's AI Navigator anything about this agency guidance, verify citations, and research related authorities. Sign up for CiteLaw free today to get started.